Abstract:Background. Approximately 10% of cancer patients worldwide have colorectal cancer (CRC), a prevalent gastrointestinal malignancy with substantial mortality and morbidity. The purpose of this work was to investigate the APOC1 gene’s expression patterns in the CRC tumor microenvironment and, using the findings from bioinformatics, to assess the biological function of APOC1 in the development of CRC. Methods. The TCGA portal was employed in this investigation to find APOC1 expression in CRC. Its correlation with other genes and clinicopathological data was examined using the UALCAN database. To validate APOC1’s cellular location, the Human Protein was employed. In order to forecast the relationship between APOC1 expression and prognosis in CRC patients, the Kaplan–Meier plotter database was used. TISIDB was also employed to evaluate the connection between immune responses and APOC1 expression in CRC. The interactions of APOC1 with other proteins were predicted using STRING. In order to understand the factors that contribute to liver metastasis from CRC, single-cell RNA sequencing (scRNA-seq) was done on one patient who had the disease. This procedure included sampling preoperative blood and the main colorectal cancer tissues, surrounding colorectal cancer normal tissues, liver metastatic cancer tissues, and normal liver tissues. Finally, an in vitro knockdown method was used to assess how APOC1 expression in tumor-associated macrophages (TAMs) affected CRC cancer cell growth and migration. Results. When compared to paracancerous tissues, APOC1 expression was considerably higher in CRC tissues. The clinicopathological stage and the prognosis of CRC patients had a positive correlation with APOC1 upregulation and a negative correlation, respectively. APOC1 proteins are mostly found in cell cytosols where they may interact with APOE, RAB42, and TREM2. APOC1 was also discovered to have a substantial relationship with immunoinhibitors (CD274, IDO1, and IL10) and immunostimulators (PVR, CD86, and ICOS). According to the results of scRNA-seq, we found that TAMs of CRC tissues had considerably more APOC1 than other cell groups. The proliferation and migration of CRC cells were impeded in vitro by APOC1 knockdown in TAMs. Conclusion. Based on scRNA-seq research, the current study shows that APOC1 was overexpressed in TAMs from CRC tissues. By inhibiting APOC1 in TAMs, CRC progression was reduced in vitro, offering a new tactic and giving CRC patients fresh hope.

TAZ Expression As a Prognostic Indicator in Colorectal Cancer.

Association Between the Expression Levels of TAZ, AXL and CTGF and Clinicopathological Parameters in Patients with Colon Cancer

The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer

Common and Unique Transcription Signatures of YAP and TAZ in Gastric Cancer Cells

Overexpression of Hippo Pathway Effector TAZ in Tongue Squamous Cell Carcinoma: Correlation with Clinicopathological Features and Patients' Prognosis.

Application of RNA Processing Factors for Predicting Clinical Outcomes in Colon Cancer.

GLTSCR1 Coordinates Alternative Splicing and Transcription Elongation of ZO1 to Regulate Colorectal Cancer Progression.

Tead Transcription Factors Mediate the Function of Taz in Cell Growth and Epithelial-Mesenchymal Transition

Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer

The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.

Expression of Hippo Pathway in Colorectal Cancer.

Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves As a Potential Therapeutic Target Based on Bioinformatics Analysis

Unveiling the oncogenic role of LZTS1 in colorectal cancer

The expression changes of transcription factors including ANKZF1, LEF1, CASZ1, and ATOH1 as a predictor of survival rate in colorectal cancer: a large-scale analysis

Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy

Prognostic Significance of TAZ Expression in Various Cancers: a Meta-Analysis.

Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer

High Expression of Taz Indicates A Poor Prognosis in Retinoblastoma

Downregulation of TEX11 promotes S-Phase progression and proliferation in colorectal cancer cells through the FOXO3a/COP1/c-Jun/p21 axis

YAP/TAZ: a promising target for squamous cell carcinoma treatment